Cargando…

Cardiac sarcoidosis presenting with cardiogenic shock successfully recovered by Impella and corticosteroid pulse therapy: a case report

BACKGROUND: Cardiac sarcoidosis (CS) occasionally disrupts circulatory haemodynamics due to arrhythmia or cardiac dysfunction. CASE SUMMARY: A 70-year-old woman was diagnosed with CS, then was admitted for syncope because of complete atrioventricular block and frequently non-sustained ventricular ta...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hashimura, Miho, Ikeda, Yuki, Koitabashi, Toshimi, Ako, Junya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9924496/ https://www.ncbi.nlm.nih.gov/pubmed/36793932 http://dx.doi.org/10.1093/ehjcr/ytad045

Ejemplares similares

Clinical valuables related to resolution of complete or advanced atrioventricular block after steroid therapy in patients with cardiac sarcoidosis
por: Nabeta, Takeru, et al.
Publicado: (2021)

Impella CP use in patients with non‐ischaemic cardiogenic shock
por: Maniuc, Octavian, et al.
Publicado: (2019)

Ventricular Unloading Using the Impella(TM) Device in Cardiogenic Shock
por: Attinger-Toller, Adrian, et al.
Publicado: (2022)

Usefulness of Impella support in different clinical settings in cardiogenic shock
por: Barrionuevo-Sánchez, María Isabel, et al.
Publicado: (2022)

Impella to Treat Acute Myocardial Infarct-Related Cardiogenic Shock
por: Møller, Jacob Eifer, et al.
Publicado: (2022)

IABP versus Impella Support in Cardiogenic Shock: “In Silico” Study
por: De Lazzari, Beatrice, et al.
Publicado: (2023)

Concomitant Use of VA-ECMO and Impella Support for Cardiogenic Shock
por: Modi, Shan P., et al.
Publicado: (2023)

Clinical outcomes and predictors of success with Impella weaning in cardiogenic shock: a single-center experience
por: Matassini, M. V., et al.
Publicado: (2023)

Use of Impella Devices for Acute Cardiogenic Shock in the Perioperative Period of Cardiac Surgery
por: Sicouri, Serge, et al.
Publicado: (2023)

Hemodynamic Support Using Percutaneous Transfemoral Impella 5.0 and Impella RP for Refractory Cardiogenic Shock
por: Dalal, Pratik K., et al.
Publicado: (2019)

Fulminant cardiogenic shock due to cardiac sarcoidosis
por: Genovese, Leonard, et al.
Publicado: (2021)

Impella versus IABP in acute myocardial infarction complicated by cardiogenic shock
por: Alushi, Brunilda, et al.
Publicado: (2019)

Use of Impella heart pump for management of women with peripartum cardiogenic shock
por: Elkayam, Uri, et al.
Publicado: (2019)

Impella use in real-world cardiogenic shock patients: Sobering outcomes
por: Abdullah, Khaled Q. A., et al.
Publicado: (2021)

Impella support as a bridge to heart surgery in patients with cardiogenic shock
por: Saito, Shunsuke, et al.
Publicado: (2022)

The Therapeutic Use of Impella Device in Cardiogenic Shock: A Systematic Review
por: Munoz Tello, Carlos, et al.
Publicado: (2022)

Management and outcome of patients supported with Impella 5.0 for refractory cardiogenic shock
por: Gaudard, Philippe, et al.
Publicado: (2015)

Correction: Impella versus IABP in acute myocardial infarction complicated by cardiogenic shock
Publicado: (2019)

The role of the axillary Impella 5.0 device on patients with acute cardiogenic shock
por: Tarabichi, Saeed, et al.
Publicado: (2020)

Cardiogenic shock in thyroid storm: A biventricular impella (Bi‐Pella) approach
por: Caruso, Evan, et al.
Publicado: (2021)

Impella Support as a Bridge to Surgery for Severe Mitral Regurgitation With Cardiogenic Shock
por: Imaoka, Shusuke, et al.
Publicado: (2021)

IMPELLA(®) or Extracorporeal Membrane Oxygenation for Left Ventricular Dominant Refractory Cardiogenic Shock
por: Schurtz, Guillaume, et al.
Publicado: (2021)

Hemostasis Matters in a Patient With an Impella 5.0 for Refractory Cardiogenic Shock
por: Nishimoto, Yuji, et al.
Publicado: (2021)

Renal Protection and Hemodynamic Improvement by Impella(®) Microaxial Pump in Patients with Cardiogenic Shock
por: Patsalis, Nikolaos, et al.
Publicado: (2022)

Subclinical Aortic Insufficiency Causing Cardiogenic Shock Years After Impella Placement
por: Syed, Ali, et al.
Publicado: (2023)

Timing of Impella implantation and outcomes in cardiogenic shock or high‐risk percutaneous coronary revascularization
por: Tarantini, Giuseppe, et al.
Publicado: (2021)

Electrical Storm Ablation in a Patient in Cardiogenic Shock Supported by Impella 5.0
por: Le Ruz, Robin, et al.
Publicado: (2021)

Pseudoaneurysm Formation After “Preclose”-Assisted Impella Insertion in a Patient With Cardiogenic Shock
por: Asemota, Daniel, et al.
Publicado: (2022)

Use of Extracorporeal Membrane Oxygenation and Impella as Bridge to Surgery Through Imaging for Cardiogenic Shock
por: Anastasius, Malcolm, et al.
Publicado: (2022)

Complications and Outcomes of Impella Treatment in Cardiogenic Shock Patients With and Without Acute Myocardial Infarction
por: Saito, Yuichi, et al.
Publicado: (2023)

Treating Refractory Cardiogenic Shock With the TandemHeart and Impella Devices: A Single Center Experience
por: Schwartz, Bryan G., et al.
Publicado: (2012)

Influence of Timing and Predicted Risk on Mortality in Impella-Treated Infarct-Related Cardiogenic Shock Patients
por: Schäfer, Andreas, et al.
Publicado: (2020)

Recurrent Stress-Induced Cardiomyopathy With Cardiogenic Shock Requiring Impella Left Ventricular Assist Device
por: Feghaly, Julien, et al.
Publicado: (2021)

Impella versus extracorporal life support in cardiogenic shock: a propensity score adjusted analysis
por: Wernly, Bernhard, et al.
Publicado: (2021)

Biventricular Impella (Bi-Pella) in Refractory Cardiogenic Shock: The First Case from the Middle East
por: Almejren, Abdulaziz, et al.
Publicado: (2021)

Impella Use in Cardiogenic Shock Due to Takotsubo Cardiomyopathy With Left Ventricular Outflow Tract Obstruction
por: Mohammedzein, Assad, et al.
Publicado: (2019)

Complete Revascularisation in Impella-Supported Infarct-Related Cardiogenic Shock Patients Is Associated With Improved Mortality
por: Schäfer, Andreas, et al.
Publicado: (2021)

Heparin-Induced Thrombocytopenia under Mechanical Circulatory Support by Large Impella for Acute Cardiogenic Shock
por: Sugimura, Yukiharu, et al.
Publicado: (2021)

Successful Treatment of Cardiogenic Shock Due to Takotsubo Cardiomyopathy With Left Ventricular Outflow Tract Obstruction and Acute Mitral Regurgitation by Impella CP
por: Benak, Ales, et al.
Publicado: (2022)

Augmenting Function for Infarction from Infection: Impella 2.5 for Ischemic Cardiogenic Shock Complicating Sepsis
por: George, Praveen, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_egpcgqqum0eptrnr85oupj17ld